European Journal of Radiology
Volume 64, Issue 3 , Pages 381-396 , December 2007

Lung MRI for experimental drug research

  • Nicolau Beckmann

      Affiliations

    • Discovery Technologies, Novartis Institutes for BioMedical Research, Lichtstr. 35, WSJ-386.2.09, CH-4002 Basel, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 61 3249576; fax: +41 61 3243889.
    • ,
  • Catherine Cannet

      Affiliations

    • Discovery Technologies, Novartis Institutes for BioMedical Research, Lichtstr. 35, WSJ-386.2.09, CH-4002 Basel, Switzerland
    • ,
  • Harry Karmouty-Quintana

      Affiliations

    • Discovery Technologies, Novartis Institutes for BioMedical Research, Lichtstr. 35, WSJ-386.2.09, CH-4002 Basel, Switzerland
    • Meakins-Christie Laboratories, McGill University, Montreal, Canada H2X 2P2
    • ,
  • Bruno Tigani

      Affiliations

    • Discovery Technologies, Novartis Institutes for BioMedical Research, Lichtstr. 35, WSJ-386.2.09, CH-4002 Basel, Switzerland
    • ,
  • Stefan Zurbruegg

      Affiliations

    • Discovery Technologies, Novartis Institutes for BioMedical Research, Lichtstr. 35, WSJ-386.2.09, CH-4002 Basel, Switzerland
    • ,
  • François-Xavier Blé

      Affiliations

    • Discovery Technologies, Novartis Institutes for BioMedical Research, Lichtstr. 35, WSJ-386.2.09, CH-4002 Basel, Switzerland
    • Respiratory Diseases Department, Novartis Institutes for BioMedical Research, CH-4056 Basel, Switzerland
    • Faculty of Pharmacy, University Louis Pasteur-Strasbourg-I, F-67401 Illkirch, France
    • ,
  • Yannick Crémillieux

      Affiliations

    • University of Lyon-1, Laboratory of Nuclear Magnetic Resonance, Centre National de la Recherche Scientifique (CNRS), F-69622 Villeurbanne, France
    • ,
  • Alexandre Trifilieff

      Affiliations

    • Respiratory Diseases Department, Novartis Institutes for BioMedical Research, CH-4056 Basel, Switzerland

Received 30 July 2007 ,Revised 31 July 2007 ,Accepted 1 August 2007.

References 

  1. In: Beckmann N  editors. In vivo MR techniques in drug discovery and development. New York: Taylor & Francis; 2006;
  2. Rudin M, Beckmann N, Porszasz TD, Bochelen , Sauter A. In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives. NMR Biomed. 1999;12:69–97
  3. Beckmann N, Mueggler T, Allegrini PR, Laurent D, Rudin M. From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research. Anat Rec. 2001;265:85–100
  4. Beckmann N, Laurent D, Tigani B, Panizzutti R, Rudin M. Magnetic resonance imaging in drug discovery: lessons from disease areas. Drug Discov Today. 2004;9:35–42
  5. Beckmann N, Tigani B, Mazzoni L, Fozard JR. Magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs. Trends Pharmacol Sci. 2003;24:550–554
  6. Kroegel C, Virchow JC, Luttmann W, Walker C, Warner JA. Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I). Eur Respir J. 1994;7(4):519–543
  7. Barnes PJ. Pathophysiology of asthma. Br J Clin Pharmacol. 1996;42:3–10
  8. Moqbel R. Eosinophil-derived cytokines in allergic inflammation and asthma. Ann N Y Acad Sci. 1996;796:209–217
  9. Barnes PJ. New Treatments for COPD. Nat Rev Drug Discov. 2002;1(6):437–446
  10. Sethi S. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2005;26(2):192–203
  11. Dawkins PA, Stockley RA. Animal models of chronic obstructive pulmonary disease. Thorax. 2001;56(12):972–977
  12. Canning BJ. Modeling asthma and COPD in animals: a pointless exercise?. Curr Op Pharmacol. 2003;3(3):244–250
  13. Isenberg-Feig H, Justice JP, Keane-Myers A. Animal models of allergic asthma. Curr Allergy Asthma Rep. 2003;3(1):70–78
  14. Renzi PM, Olivenstein R, Martin JG. Inflammatory cell populations in the airways and parenchyma after antigen challenge in the rat. Am Rev Resp Dis. 1993;147:967–974
  15. Haczku A, Macary P, Huang TJ, et al. Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats. Immunology. 1997;91(2):176–185
  16. Hannon JP, Tigani B, Williams I, Mazzoni L, Fozard JR. Mechanism of airway hyperresponsiveness to adenoside induced by allergen challenge in actively sensitized Brown Norway rats. Br J Pharmacol. 2001;132(7):1509–1523
  17. Watson RW, Redmond HP, Bouchier-Hayes D. Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses. J Leukoc Biol. 1994;56(1):95–103
  18. Yang RB, Mark MR, Gray A, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 1998;395(6699):284–288
  19. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504–512
  20. Tesfaigzi Y, Fischer MJ, Martin AJ, Seagrave J. Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1210–L1217
  21. Tigani B, Schaeublin E, Sugar R, Jackson AD, Fozard JR, Beckmann N. Pulmonary inflammation monitored non-invasively by MRI in freely breathing rats. Biochem Biophys Res Commun. 2002;292:216–221
  22. Harkema JR, Hotchkiss JA. In vivo effects of endotoxin on intraepithelial mucosubstances in rat pulmonary airways. Quantitative histochemistry. Am J Pathol. 1992;141:307–317
  23. Beckmann N, Tigani B, Mazzoni L, Fozard JR. MRI of lung parenchyma in rats and mice using a gradient-echo sequence. NMR Biomed. 2001;14:297–306
  24. Bergin CJ, Pauly JM, Macovski A. Lung parenchyma: projection reconstruction MR imaging. Radiology. 1991;179:777–781
  25. Gewalt SL, Glover GH, Hedlund LW, Cofer GP, MacFall JR, Johnson GA. MR microscopy of the rat lung using projection reconstruction. Magn Reson Med. 1993;29:99–106
  26. Liao JR, Pauly JM, Brosnan TJ, Pelc NJ. Reduction of motion artifacts in cine MRI using variable-density spiral trajectories. Magn Reson Med. 1997;37:569–575
  27. Hedlund LW, Cofer GP, Owen SJ, Johnson GA. MR-compatible ventilator for small animals: computer-controlled ventilation for proton and noble gas imaging. Magn Reson Imaging. 2000;18:753–759
  28. Karzai W, Cui X, Heinicke N, et al. Neutrophil stimulation with granulocyte colony-stimulating factor worsens ventilator-induced lung injury and mortality in rats. Anesthesiology. 2005;103:996–1005
  29. Peng X, Abdulnour RE, Sammani S, et al. Inducible nitric oxide synthase contributes to ventilator-induced lung injury. Am J Respir Crit Care Med. 2005;172:470–479
  30. Walder B, Fontao E, Totsch M, Morel DR. Time and tidal volume-dependent ventilator-induced lung injury in healthy rat. Eur J Anaesthesiol. 2005;10:785–794
  31. Beckmann N, Tigani B, Ekatodramis D, Borer R, Mazzoni L, Fozard JR. Pulmonary edema induced by allergen challenge in the rat: noninvasive assessment by magnetic resonance imaging. Magn Reson Med. 2001;45:88–95
  32. Edelman RR, Hatabu H, Tadamura E, Li W, Prasad PV. Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging. Nature Med. 1991;2:1236–1239
  33. Beckmann N, Cannet C, Zurbruegg S, Rudin M, Tigani B. Proton MRI of lung parenchyma reflects allergen-induced airway remodeling and endotoxin-aroused hyporesponsiveness: a step towards ventilation studies in spontaneously breathing rats. Magn Reson Med. 2004;52:258–268
  34. Kuethe DO, Caprihan A, Fukushima E, Waggoner RA. Imaging lungs using inert fluorinated gases. Magn Reson Med. 1998;39:85–88
  35. Kuethe DO, Caprihan A, Gach HM, Lowe IJ, Fukushima E. Imaging obstructed ventilation with NMR using inert fluorinated gases. J Appl Physiol. 2000;88:2279–2286
  36. Kuethe DO, Behr VC, Begay S. Volume of rat lungs measured throughout the respiratory cycle using 19F NMR of the inert gas SF6. Magn Reson Med. 2002;48:547–549
  37. Goodson BM. Nuclear magnetic resonance of laser-polarized noble gases in molecules, materials, and organisms. J Magn Reson. 2002;155:157–216
  38. Möller HE, Chen XJ, Saam B, et al. MRI of the Lungs Using Hyperpolarized Noble Gases. Magn Reson Med. 2002;47:1029–1051
  39. Albert MS, Cates GD, Driehuys B, et al. Biological magnetic resonance imaging using laser-polarized 129Xe. Nature. 1994;370:199–201
  40. Middleton H, Black RD, Saam B, et al. MR imaging with hyperpolarized 3He gas. Magn Reson Med. 1995;33:271–275
  41. Chen XJ, Hedlund L, Moller HE, Chawla MS, Maronpot RR, Johnson GA. Detection of emphysema in rat lungs by using magnetic resonance measurements of 3He diffusion. Proc Natl Acad Sci USA. 2000;97:11478–11481
  42. Chen BT, Brau AC, Johnson GA. Measurement of regional lung function in rats using hyperpolarized 3helium dynamic MRI. Magn Reson Med. 2003;49:78–88
  43. Dupuich D, Berthezene Y, Clouet PL, Stupar V, Canet E, Cremillieux Y. Dynamic 3He imaging for quantification of regional lung ventilation parameters. Magn Reson Med. 2003;50:777–783
  44. Chen BT, Johnson GA. Dynamic lung morphology of methacholine-induced heterogeneous bronchoconstriction. Magn Reson Med. 2004;52:1080–1086
  45. Imai H, Narazaki M, Inoshita H, Kimura A, Fujiwara H. MR imaging of mouse lung using hyperpolarized 3He: image acquisition and T1 estimation under spontaneous respiration. Magn Reson Med Sci. 2006;5:57–64
  46. Mosbah K, Cremillieux Y, Adeleine P, et al. Quantitative measurements of regional lung ventilation using helium-3 MRI in a methacholine-induced bronchoconstriction model. J Magn Reson Imaging. 2006;24:611–616
  47. Stupar V, Berthezene Y, Canet E, Tournier H, Dupuich D, Cremillieux Y. Helium3 polarization using spin exchange technique: application to simultaneous pulmonary ventilation/perfusion imaging in small animals. Invest Radiol. 2003;38:334–340
  48. Stupar V, Canet-Soulas E, Gaillard S, Alsaid H, Beckmann N, Cremillieux Y. Retrospective cine (3)He ventilation imaging under spontaneous breathing conditions: a non-invasive protocol for small-animal lung function imaging. NMR Biomed. 2007;20:104–112
  49. Oros AM, Shah NJ. Hyperpolarized xenon in NMR and MRI. Phys Med Biol. 2004;49:R105–R153
  50. Narazaki M, Wakayama T, Imai H, Kimura A, Fujiwara H. Analysis of hyperpolarized 129Xe dynamics in mouse lungs under spontaneous respiration for separate determination of lung functional parameters and relaxation time. Magn Reson Med Sci. 2006;5:119–128
  51. Driehuys D, Cofer GP, Pollaro J, Mackel JB, Hedlund LW, Johnson GA. Imaging alveolar-capillary gas transfer using hyperpolarized 129Xe MRI. Proc Natl Acad Sci USA. 2006;103:18278–18283
  52. Hedlund LW, Moller HE, Chen XJ, Chawla MS, Cofer GP, Johnson GA. Mixing oxygen with hyperpolarized (3)He for small-animal lung studies. NMR Biomed. 2000;13:202–206
  53. Ramirez MP, Sigaloff KC, Kubatina LV, Donahue MA, Venkatesh AK, Albert MS. Physiological response of rats to delivery of helium and xenon: implications for hyperpolarized noble gas imaging. NMR Biomed. 2000;13:253–264
  54. Chen BT, Yordanov AT, Johnson GA. Ventilation-synchronous magnetic resonance microscopy of pulmonary structure and ventilation in mice. Magn Reson Med. 2005;53:69–75
  55. Hatabu H, Gaa J, Kim D, Li W, Prasad PV, Edelman RR. Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery Turbo FLASH. Magn Reson Med. 1996;36:503–508
  56. Mai VM, Liu B, Polzin JA, et al. Ventilation-perfusion ratio of signal intensity in human lung using oxygen-enhanced and arterial spin labeling techniques. Magn Reson Med. 2002;48:341–350
  57. Lipson DA, Roberts DA, Hansen-Flaschen J, et al. Pulmonary ventilation and perfusion scanning using hyperpolarized helium-3 MRI and arterial spin tagging in healthy normal subjects and in pulmonary embolism and orthotopic lung transplant patients. Magn Reson Med. 2002;47:1073–1076
  58. Berthezène Y, Vexler V, Clement O, Muhler A, Moseley ME, Brasch RC. Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion. Radiology. 1992;183:667–672
  59. Crémillieux Y, Berthezene Y, Humblot H, et al. A combined 1H perfusion/3He ventilation NMR study in rat lungs. Magn Reson Med. 1999;47:645–648
  60. Viallon M, Berthezene Y, Decorps M, et al. Laser-polarized 3He as a probe for dynamic regional measurements of lung perfusion and ventilation using magnetic resonance imaging. Magn Reson Med. 2000;44:1–4
  61. Callot V, Canet E, Brochot J, et al. MR perfusion imaging using encapsulated laser-polarized 3He. Magn Reson Med. 2001;46:535–540
  62. Callot V, Canet E, Brochot J, et al. Hyperpolarized helium3 encapsulated in microbubbles: a new class of blood pool MRI contrast agent. Acad Radiol. 2002;9:S501–S503
  63. Wilkinson MH, Berger PJ, Blanch N, Brodecky V. Effect of venous oxygenation on arterial desaturation rate during repetitive apneas in lambs. Respir Physiol. 1995;101:321–331
  64. West JB. Respiratory physiology: the essentials. 6th ed.. Baltimore: Lippincott Williams & Wilkins; 1999;
  65. Saam B, Happer W, Middleton H. Nuclear relaxation of 3He in the presence of O2. Phys Rev A. 1995;52:862–865
  66. Deninger AJ, Eberle B, Ebert M, et al. Quantification of regional intrapulmonary oxygen partial pressure evolution during apnea by 3He MRI. J Magn Reson. 1999;141:207–216
  67. Wild JM, Fischele S, Woodhouse N, Paley MNJ, Kasuboski L, van Beek EJR. 3D volume-localized pO2 measurement in the human lung with 3He MRI. Magn Reson Med. 2005;53:1055–1064
  68. Deninger AJ, Eberle B, Bermuth J, et al. Assessment of a single-acquisition imaging sequence for oxygen-sensitive 3He. Magn Reson Med. 2002;47:105–114
  69. Fischer MC, Spector ZZ, Ishii M, et al. Single-acquisition sequence for the measurement of oxygen partial pressure by hyperpolarized gas MRI. Magn Reson Med. 2004;52:766–773
  70. Jalali A, Ishii M, Edvinsson JM, et al. Detection of simulated pulmonary embolism in a porcine model using hyperpolarized 3He MRI. Magn Reson Med. 2004;51:291–298
  71. Yu J, Fischer MC, Ishii M, et al. Measurements of regional alveolar oxygen pressure and oxygen depletion rate by hyperpolarized 3He MRI in small animals. In: Proceedings of the 13th Annual Meeting of ISMRM. Miami Beach, FL, USA. 2005;(Abstract 1830)
  72. Möller HE, Hedlund LW, Chen XJ, et al. Measurements of hyperpolarized gas properties in the lung. Part III: 3He T1. Magn Reson Med. 2001;45:421–430
  73. Cieślar K, Stupar V, Canet-Soulas E, Gaillard S, Crémillieux Y. Alveolar oxygen partial pressure and oxygen depletion rate mapping in rats using 3He ventilation imaging. Magn Reson Med. 2007;57:423–430
  74. Cieślar K, Alsaid H, Stupar V, et al. Measurement of nonlinear pO2 decay in mouse lungs using 3He-MRI. NMR Biomed. 2007;20:383–391
  75. Tigani B, Cannet C, Zurbruegg S. Resolution of the oedema associated with allergic pulmonary inflammation in rats. Br J Pharmacol. 2003;140:239–246
  76. Tigani B, Cannet C, Quintana HK, et al. Lung inflammation and vascular remodeling after repeated allergen challenge detected noninvasively by MRI. Am J Physiol Lung Cell Mol Physiol. 2007;292:L644–L653
  77. Beckmann N, Tigani B, Sugar R, et al. Non-invasive detection of endotoxin induced mucus hypersecretion in rat lung by magnetic resonance imaging. Am J Physiol Lung Cell Mol Physiol. 2002;283:L22–L30
  78. Saam BT, Yablonskiy DA, Kodibagkar VD, et al. MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magn Reson Med. 2000;44:174–179
  79. Salerno M, de Lange EE, Altes TA, Truwit JD, Brookeman JR, Mugler JP. Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes–initial experience. Radiology. 2002;222:252–260
  80. Salerno M, Altes TA, Brookeman JR, de Lange EE, Mugler JP. Rapid hyperpolarized 3He diffusion MRI of healthy and emphysematous human lungs using an optimized interleaved-spiral pulse sequence. J Magn Reson Imaging. 2003;7:1–588
  81. Busch RH, Lauhala KE, Loscutoff SM, McDonald KE. Experimental pulmonary emphysema induced in the rat by intratracheally administered elastase: morphogenesis. Environ Res. 1984;3:97–513
  82. Peces-Barba G, Ruiz-Cabello J, Cremillieux Y, et al. Helium-3 MRI diffusion coefficient: correlation to morphometry in a model of mild emphysema. Eur Respir J. 2003;2:4–19
  83. Dugas JP, Garbow JR, Kobayashi DK, Conradi MS. Hyperpolarized (3)He MRI of mouse lung. Magn Reson Med. 2004;2:310–1317
  84. Quintana HK, Cannet C, Zurbruegg S, et al. Proton MRI as a noninvasive tool to assess elastase-induced lung damage in spontaneously breathing rats. Magn Reson Med 2006;56:1242–50.
  85. Shapiro SD. Animal models for COPD. Chest. 2000;117:223S–227S
  86. Belloni PN, Garvin L, Mao CP, Bailey-Healy I, Leaffer D. Effects of all-trans-retinoic acid in promoting alveolar repair. Chest. 2000;117:235S–241S
  87. Heverhagen JT, Hahn HK, Wegmann M, et al. Volumetric analysis of mice lungs in a clinical magnetic resonance imaging scanner. MAGMA. 2004;17:80–85
  88. Lundblad KAL, Irvin CG, Adler A, Bates JHT. A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol. 2002;93:1198–1207
  89. Bates JH, Irvin CG. Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol. 2003;94:1297–1306
  90. Beckmann N, Crémillieux Y, Tigani B, Quintana HK, Blé FX, Fozard JR. Lung MRI in small rodents as a tool for the evaluation of drugs in models of airways diseases. In:  Beckmann N editors. In vivo MR techniques in drug discovery and development. New York: Taylor & Francis; 2006;p. 351–372
  91. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study. Am Rev Respir Dis. 1993;148:720–726
  92. Martin JG, Duguet A, Eidelman DH. The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease. Eur Respir J. 2000;16:349–354
  93. Halayko AJ, Amrani Y. Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol. 2003;137:209–222
  94. Pauwels RA, Kips JC, Peleman RA, van der Straeten ME. The effect of endotoxin inhalation on airway responsiveness and cellular influx in rats. Am Rev Respir Dis. 1990;141:540–545
  95. Kips JC, Lefebvre RA, Peleman RA, Joos GF, Pauwels RA. The effect of a nitric oxide synthase inhibitor on the modulation of airway responsiveness in rats. Am J Respir Crit Care Med. 1995;151:1165–1169
  96. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993;9:371–377
  97. Abderrahmane A, Salvail D, Dumoulin M, Garon J, Cadieux A, Rousseau E. Direct activation of KCa channel in airway smooth muscle by nitric oxide: Involvement of a nitrothiosylation mechanism?. Am J Respir Cell Mol Biol. 1998;19:485–497
  98. Lazenby AJ, Crouch EC, McDonald JA, Kuhn C. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am Rev Respir Dis. 1990;142:206–214
  99. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathological classification. Am J Respir Crit Care Med. 1998;157:1301–1315
  100. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517–525
  101. Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1990;3:507–511
  102. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989;1:520–524
  103. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol. 2000;105:193–204
  104. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164:S28–S38
  105. International consensus statement 2000. Idiopathic pulmonary fibrosis: diagnosis and treatment, Am J Respir Crit Care Med 161;2000:646–64.
  106. Ueda Y, Saito A, Fukuoka Y, et al. Interactions of beta-lactam antibiotics and antineoplastic agents. Antimicrob Agents Chemother. 1983;23:374–378
  107. Snider GL, Hayes JA, Korthy AL. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. Am Rev Respir Dis. 1978;117:1099–1108
  108. Hay J, Shahzeidi S, Laurent G. Mechanisms of bleomycin-induced lung damage. Arch Toxicol. 1991;65:81–94
  109. Aso Y, Yoneda K, Kikkawa Y. Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Labor Invest. 1976;35:558–568
  110. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83:111–211
  111. Karmouty-Quintana H, Cannet C, Zurbruegg S, et al. Bleomycin-induced lung injury assessed non-invasively in spontaneously breathing rats by proton MRI, J Magn Reson Imaging, in press.
  112. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173:769–776
  113. Tani K, Yasuoka S, Ogushi F, et al. Thrombin enhances lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991;5:34–40
  114. Walsh J, Absher M, Kelley J. Variable expression of platelet-derived growth factor family proteins in acute lung injury. Am J Respir Cell Mol Biol. 1993;9:637–644
  115. Rogers DF. Airway mucus hypersecretion in asthma: an undervalued pathology?. Curr Opin Pharmacol. 2004;4:241–250
  116. Rogers DF. Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options. Pulm Pharmacol Ther. 2005;18:1–8
  117. Vestbo J, Prescott E, Lange P Copenhagen City Heart Study Group. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med. 1996;153:1530–1535
  118. Melton L. Does mucus hypersecretion matter in airway disease?. Lancet. 2002;359:1924
  119. Rogers DF. Neurogenic inflammation in lung disease: burn out?. Inflammopharmacol. 1997;5:319–329
  120. Joos GF, De Swert KO, Schelfhout V, Pauwels RA. The role of neural inflammation in asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci. 2003;992:218–230
  121. Patacchini R, Maggi CA. Tachykinin receptors and receptor subtypes. Arch Int Pharmacodyn Ther. 1995;329:161–184
  122. Mapp CE, Miotto D, Braccioni F, et al. The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. Am J Respir Crit Care Med. 2000;161:207–215
  123. Germonpre PR, Joos GF, Everaert E, Kips JC, Pauwels RA. Characterization of neurogenic inflammation in the airways of two highly inbred rat strains. Am J Respir Crit Care Med. 1995;152:1796–1804
  124. Rogers DF. Motor control of airway goblet cells and glands. Resp Physiol. 2001;125:129–144
  125. Reynolds PN, Holmes MD, Scicchitano R. Role of tachykinins in bronchial hyper-responsiveness. Clin Exp Pharmacol Physiol. 1997;24:273–280
  126. Karmouty-Quintana HK, Cannet C, Sugar R, Fozard JR, Page CP, Beckmann N. Capsaicin-induced mucus secretion in the airways evidenced in vivo and non-invasively by magnetic resonance imaging (MRI). Br J Pharmacol. 2007;150:1022–1030
  127. Barnes BJ. New drugs for asthma. Nat Rev Drug Discov. 2004;3:831–844
  128. Trifilieff A, Wyss D, Walker C, Mazzoni L, Hersperger R. Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities. J Pharmacol Exp Ther. 2002;301:241–248
  129. Tigani B, Di Padova F, Zurbruegg S, et al. Effects of a mitogen-activated protein kinase inhibitor on allergic airways inflammation in the rat studied by magnetic resonance imaging. Eur J Pharmacol. 2003;482:319–324
  130. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med. 1997;3:675–677
  131. Massaro D, Massaro GD. Retinoids, alveolus formation, and alveolar deficiency: clinical implications. Am J Respir Cell Mol Biol. 2003;28:271–274
  132. Fujita M, Ye Q, Ouchi H, et al. Retinoic acid fails to reverse emphysema in adult mouse models. Thorax. 2004;59:224–230
  133. March TH, Cossey PY, Esparza DC, Dix KJ, McDonald JD, Bowen LE. Inhalation administration of all-trans-retinoic acid for treatment of elastase-induced pulmonary emphysema in Fischer 344 rats. Exp Lung Res. 2004;30:383–404
  134. Nishi Y, Boswell V, Ansari T, Piprawala F, Satchi S, Page CP. Elastase-induced changes in lung function: relationship to morphometry and effect of drugs. Pulm Pharmacol Ther. 2003;16:221–229
  135. Mao JT, Goldin JG, Dermand J, et al. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med. 2002;165:718–723
  136. Olsson LE, Lindahl M, Onnervik PO, et al. Measurement of MR signal and T2* in lung to characterize a tight skin mouse model of emphysema using single-point imaging. J Magn Reson Imaging. 2007;25:488–494
  137. Schuster DP, Kovacs A, Garbow J, Piwnica-Worms D. Recent advances in imaging the lungs of intact small animals. Am J Respir Cell Mol Biol. 2004;30:129–138
  138. Driehuys B, Hedlund LW. Imaging techniques for small animal models of pulmonary disease: MR microscopy. Toxicol Pathol. 2007;35:49–58
  139. Beckmann N, Kneuer R, Gremlich HU, Karmouty-Quintana H, Ble FX, Muller M. In vivo mouse imaging and spectroscopy in drug discovery. NMR Biomed. 2007;20:154–185
  140. Griese M, Essl R, Schmidt R, et al. BEAT Study Group Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis. Am J Respir Crit Care Med. 2004;170:1000–1005

PII: S0720-048X(07)00394-4

doi: 10.1016/j.ejrad.2007.08.012

European Journal of Radiology
Volume 64, Issue 3 , Pages 381-396 , December 2007

Article Tools

* Image Usage & Resolution